Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database access restrictions

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 4 result(s)

Coronavirus Antiviral Research Database

COVDB

Subject(s)
Content type(s)
Country
The Coronavirus Antiviral Research Database is designed to expedite the development of SARS-CoV-2 antiviral therapy. It will benefit global coronavirus drug development efforts by (1) promoting uniform reporting of experimental results to facilitate comparisons between different candidate antiviral compounds; (2) identifying gaps in coronavirus antiviral drug development research; (3) helping scientists, clinical investigators, public health officials, and funding agencies prioritize the most promising compounds and repurposed drugs for further development; (4) providing an objective, evidenced-based, source of information for the public; and (5) creating a hub for the exchange of ideas among coronavirus researchers whose feedback is sought and welcomed. By comprehensively reviewing all published laboratory, animal model, and clinical data on potential coronavirus therapies, the Database makes it unlikely that promising treatment approaches will be overlooked. In addition, by making it possible to compare the underlying data associated with competing treatment strategies, stakeholders will be better positioned to prioritize the most promising anti-coronavirus compounds for further development.

Laboratory of Neuroimaging Image & Data Archive

LONI Image & Data Archive

Subject(s)
Content type(s)
Country
LONI’s Image and Data Archive (IDA) is a secure data archiving system. The IDA uses a robust infrastructure to provide researchers with a flexible and simple interface for de-identifying, searching, retrieving, converting, and disseminating their biomedical data. With thousands of investigators across the globe and more than 21 million data downloads to data, the IDA guarantees reliability with a fault-tolerant network comprising multiple switches, routers, and Internet connections to prevent system failure.

METIS

FMI’s Research Data Repository

Subject(s)
Content type(s)
Country
Finnish Meteorological Institute (FMI) research data repository METIS is provided by EUDAT and enables the institute data to be preserved, discovered, and accessed. FMI covers a wide range of research on weather, sea, climate and space. According to the FMI's Research Data policy , publicly funded research data must be made available to the widest possible audience (under CC BY license, at the minimum), as the best way to maximize the data impact but also to do justice to all the hard labor put into collecting, cleaning, and analyzing the data.

burckhardtsource.org

The European correspondence to Jacob Burckhardt

Subject(s)
Content type(s)
Country
The platform hosts the critical edition of the letters written to Jacob Burckhardt, reconstructing in open access one of the most important European correspondences of the 19th century. Save a few exceptions, these letters are all unpublished. On a later stage, the project aims to publish also Jacob Burckhardt’s letters. The editing process has been carried out using Muruca semantic digital library framework. The Muruca framework has been modified over the project, as the requirements of the philological researchers emerged more clearly. The results are stored in and accessible from the front-end of the platform.